MAIA Stock Overview
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer.
MAIA Biotechnology, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$3.50|
|52 Week High||US$9.64|
|52 Week Low||US$3.10|
|1 Month Change||0%|
|3 Month Change||-8.14%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-21.53%|
Recent News & Updates
|MAIA||US Biotechs||US Market|
Return vs Industry: Insufficient data to determine how MAIA performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how MAIA performed against the US Market.
|MAIA Average Weekly Movement||10.4%|
|Biotechs Industry Average Movement||11.1%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: MAIA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: Insufficient data to determine MAIA's volatility change over the past year.
About the Company
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
MAIA Biotechnology, Inc. Fundamentals Summary
|MAIA fundamental statistics|
Is MAIA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MAIA income statement (TTM)|
|Cost of Revenue||US$0|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-1.37|
|Net Profit Margin||0.00%|
How did MAIA perform over the long term?See historical performance and comparison